326 related articles for article (PubMed ID: 33225924)
1. Modification of the 8th American Joint Committee on Cancer staging system for gallbladder carcinoma to improve prognostic precision.
Jiang W; Zhao B; Li Y; Qi D; Wang D
BMC Cancer; 2020 Nov; 20(1):1129. PubMed ID: 33225924
[TBL] [Abstract][Full Text] [Related]
2. Modified staging classification of gallbladder carcinoma on the basis of the 8
Wang J; Bo X; Shi X; Suo T; Xin Y; Nan L; Wang C; Ni X; Liu H; Pan H; Shen S; Li M; Lu P; Zhang D; Wang Z; Wang Y; Liu H
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):527-533. PubMed ID: 31630931
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the external validity of the American Joint Committee on Cancer 8th staging system for anal carcinoma.
Oweira H; Giryes A; Mannhart M; Decker M; Schlumpf R; Abdel-Rahman O
Curr Med Res Opin; 2018 May; 34(5):923-929. PubMed ID: 29448859
[TBL] [Abstract][Full Text] [Related]
4. Challenging a dogma; AJCC 8th staging system is not sufficient to predict outcomes of patients with malignant pleural mesothelioma.
Abdel-Rahman O
Lung Cancer; 2017 Nov; 113():128-133. PubMed ID: 29110839
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the prognostic value of the 8th AJCC staging system for patients with clinically staged prostate cancer; A time to sub-classify stage IV?
Abdel-Rahman O
PLoS One; 2017; 12(11):e0188450. PubMed ID: 29182656
[TBL] [Abstract][Full Text] [Related]
6. Modified the 8th AJCC staging system for patients with advanced prostate cancer: a study based on SEER database.
Sun C; Yang D; Zhu J; Zhou Y; Xiang C; Wu S
BMC Urol; 2022 Nov; 22(1):185. PubMed ID: 36384495
[TBL] [Abstract][Full Text] [Related]
7. Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC/UICC Staging System Based on the SEER Database.
Yang F; Zhong Q; Huang Z; Lian M; Fang J
Front Endocrinol (Lausanne); 2019; 10():10. PubMed ID: 30733707
[No Abstract] [Full Text] [Related]
8. Proposal and validation of a modified staging system to improve the prognosis predictive performance of the 8th AJCC/UICC pTNM staging system for gastric adenocarcinoma: a multicenter study with external validation.
Fang C; Wang W; Deng JY; Sun Z; Seeruttun SR; Wang ZN; Xu HM; Liang H; Zhou ZW
Cancer Commun (Lond); 2018 Nov; 38(1):67. PubMed ID: 30454049
[TBL] [Abstract][Full Text] [Related]
9. Validation of the 8th Edition American Joint Commission on Cancer (AJCC) Gallbladder Cancer Staging System: Prognostic Discrimination and Identification of Key Predictive Factors.
Giannis D; Cerullo M; Moris D; Shah KN; Herbert G; Zani S; Blazer DG; Allen PJ; Lidsky ME
Cancers (Basel); 2021 Feb; 13(3):. PubMed ID: 33535552
[TBL] [Abstract][Full Text] [Related]
10. Validation of the AJCC 8th lung cancer staging system among patients with small cell lung cancer.
Abdel-Rahman O
Clin Transl Oncol; 2018 Apr; 20(4):550-556. PubMed ID: 28808860
[TBL] [Abstract][Full Text] [Related]
11. Equipping the 8th Edition American Joint Committee on Cancer Staging for Gastric Cancer with the 15-Node Minimum: a Population-Based Study Using Recursive Partitioning Analysis.
Yuan SQ; Chen YT; Huang ZP
J Gastrointest Surg; 2017 Oct; 21(10):1591-1598. PubMed ID: 28752402
[TBL] [Abstract][Full Text] [Related]
12. Inclusion of the Number of Metastatic Lymph Nodes in the Staging System for Medullary Thyroid Cancer: Validating a Modified American Joint Committee on Cancer Tumor-Node-Metastasis Staging System.
Wang Z; Tang C; Wang Y; Yin Z; Rixiati Y
Thyroid; 2022 May; 32(5):536-543. PubMed ID: 35350868
[No Abstract] [Full Text] [Related]
13. Proposed Modification of the 8th Edition of the AJCC Staging System for Gastric Cancer.
Jiang Y; Tu R; Lu J; Zhang Y; Zhu J; Tang W; Gu M; Huang C; Gu X
J Invest Surg; 2020 Dec; 33(10):932-938. PubMed ID: 30885025
[No Abstract] [Full Text] [Related]
14. Validation of the American Joint Committee on Cancer (AJCC) 8th edition stage system for gastric cancer patients: a population-based analysis.
He X; Wu W; Lin Z; Ding Y; Si J; Sun LM
Gastric Cancer; 2018 May; 21(3):391-400. PubMed ID: 29052053
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the discriminating value of the 8th AJCC stage grouping for hepatocellular carcinoma.
Abdel-Rahman O
HPB (Oxford); 2018 Jan; 20(1):41-48. PubMed ID: 28882455
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the American Joint Commission on Cancer 8th Edition Staging System for Patients with Pancreatic Neuroendocrine Tumors: A Surveillance, Epidemiology, and End Results analysis.
Li X; Gou S; Liu Z; Ye Z; Wang C
Cancer Med; 2018 Mar; 7(3):626-634. PubMed ID: 29380547
[TBL] [Abstract][Full Text] [Related]
17. Integration the biologic factors into the staging of breast cancer patients with ipsilateral supraclavicular lymph node metastasis.
Lian CL; Cai XY; Zhou P; Wang J; Chen XB; Wu SG
J Cancer; 2020; 11(23):6834-6840. PubMed ID: 33123274
[No Abstract] [Full Text] [Related]
18. Validation of American Joint Committee on Cancer eighth staging system for gallbladder cancer and its lymphadenectomy guidelines.
Lee AJ; Chiang YJ; Lee JE; Conrad C; Chun YS; Aloia TA; Vauthey JN; Tzeng CD
J Surg Res; 2018 Oct; 230():148-154. PubMed ID: 30100032
[TBL] [Abstract][Full Text] [Related]
19. Validation of the 8th AJCC staging system for gastric cancer in a population-based setting.
Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):525-530. PubMed ID: 29198151
[TBL] [Abstract][Full Text] [Related]
20. Revisiting the AJCC staging system of adrenocortical carcinoma.
Abdel-Rahman O
J Endocrinol Invest; 2022 Jan; 45(1):89-94. PubMed ID: 34170487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
